Close Menu

This story has been updated from a previous version to include comments made by Fluidigm President and CEO Chris Linthwaite on an earnings call.

NEW YORK – Fluidigm reported after the close of the market on Monday that its fourth quarter revenues were essentially flat year over year, in line with preliminary revenues reported by the company in mid-January.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.